Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TCAIM gene

Known as: DKFZp313N0621, T-cell activation inhibitor, mitochondrial, TOAG-1 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
We previously showed that the T cell activation inhibitor, mitochondrial (Tcaim) is highly expressed in grafts of tolerance… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
BackgroundInduction therapy can improve kidney transplantation (KTx) outcomes, but little is known about the mechanisms… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Primary T cell activation and effector cell differentiation is required for rejection of allogeneic grafts in naïve recipients… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Background Molecular signatures have recently been identified in operationally tolerant long-term kidney transplant patients… Expand
Is this relevant?
2013
2013
Background We report on a pilot study investigating the feasibility of early immunosuppression withdrawal after liver… Expand
Is this relevant?
2012
2012
Recent data suggest that donor‐specific memory T cells (Tmem) are an independent risk factor for rejection and poor graft… Expand
Is this relevant?
2009
2009
Immune modulating therapies gain increasing importance in treatment of patients with autoimmune diseases such as psoriasis. None… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The clinical success of new treatment strategies aiming on inducing permanent graft acceptance will rely on the ability to… Expand
Is this relevant?